AMGN

2024Q4AMC

Amgen Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-02-04 · Fiscal end 2024-12-31 · Features as of 2025-02-04

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS5.08
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.6%
IV front—
P/C full—
P/C front—
Features as of2025-02-04

Run-up

Close—
Ret 5d+3.1%
Ret 10d+5.2%
Ret 20d+10.6%
Ret 30d+11.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.31Beat
Estimated EPS5.08
Actual revenue
9.1B
Surprise %+4.5%
Beat / missBeat
Beat streak 42
Beat streak 82

Reaction

1-day stock reaction+5.9%
Implied vs actual

Implied 1.6%Actual 0.6%

Gap reaction+0.6%
Day result+6.5%
Next-day upYes
Realized / IV0.35×

Post tape

Post 5d-4.1%
Post 10d-3.2%
Post volume5.9M
Vol ×10d1.91×
Vol ×20d1.85×
Post range6.4%